INDIVIOR PLC FILES 2023 ANNUAL REPORT ON FORM 20-F

Company

Indivior Pharmaceuticals, Inc.

Filed

March 7, 2024

Period of Report

March 7, 2024

Accession Number

0001654954-24-002773